Cytokeratin alterations leading to MDB formation in non-malignant liver disorders are complex and involve not only an imbalance in CK8/CK18 transcription levels, but also posttranslational modifications, such as ubiquitination, phosphorylation, transglutamination and sumoylation [24]. This evidence concerns the gene KRT18 and liver disorder.